Fundz

Lapix Therapeutics reported raising $2.2 Million in an initial SEC Form D filing, from an offering of $5 Million

PRIVATEAug 05, 2025

Amount Raised

$2.2 Million

$2.2 Million sold, per SEC Form D (first sale Jul 21, 2025)

Round Type

Seed

BostonInformation TechnologyBiotechnologyHealth CareTherapeutics

Who to call at Lapix Therapeutics, and when

A new round usually means Lapix Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Lapix Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Lapix Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Lapix Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Lapix Therapeutics

Location

75 KNEELAND STREET

Boston, Massachusetts, United States

About

LAPIX Therapeutics, Inc. is a biopharmaceutical company focused on developing novel, orally bioavailable immune system restoration therapies for autoimmune diseases. The company is dedicated to transforming how medical communities treat and support patients diagnosed with serious and complex autoimmune diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Lapix Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts hidden hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Lapix Therapeutics's next move

See what Strategic adds

Lapix Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.